{"nct_id":"NCT02684292","title":"Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2016-05-23","start_date_type":"ACTUAL","primary_completion_date":"2026-01-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}